JPH0333126B2 - - Google Patents

Info

Publication number
JPH0333126B2
JPH0333126B2 JP59253903A JP25390384A JPH0333126B2 JP H0333126 B2 JPH0333126 B2 JP H0333126B2 JP 59253903 A JP59253903 A JP 59253903A JP 25390384 A JP25390384 A JP 25390384A JP H0333126 B2 JPH0333126 B2 JP H0333126B2
Authority
JP
Japan
Prior art keywords
glycyrrhetinic acid
theophylline
sodium
carbenoxolone
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59253903A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60136514A (ja
Inventor
Yatsukuuchaan Wan Biatorisu
Yuakin Sakura Hooru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biorex Laboratories Ltd
Original Assignee
Biorex Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Laboratories Ltd filed Critical Biorex Laboratories Ltd
Publication of JPS60136514A publication Critical patent/JPS60136514A/ja
Publication of JPH0333126B2 publication Critical patent/JPH0333126B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP59253903A 1983-12-02 1984-11-29 抗炎症抗潰瘍性組成物 Granted JPS60136514A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB83.32265 1983-12-02
GB838332265A GB8332265D0 (en) 1983-12-02 1983-12-02 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JPS60136514A JPS60136514A (ja) 1985-07-20
JPH0333126B2 true JPH0333126B2 (enrdf_load_stackoverflow) 1991-05-16

Family

ID=10552750

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59253903A Granted JPS60136514A (ja) 1983-12-02 1984-11-29 抗炎症抗潰瘍性組成物

Country Status (4)

Country Link
JP (1) JPS60136514A (enrdf_load_stackoverflow)
DE (1) DE3443858A1 (enrdf_load_stackoverflow)
FR (1) FR2555899B1 (enrdf_load_stackoverflow)
GB (2) GB8332265D0 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62164650A (ja) * 1986-01-17 1987-07-21 Maruzen Kasei Kk グリチルレチン酸誘導体およびこれを含有する抗潰瘍剤
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions

Also Published As

Publication number Publication date
GB2150435B (en) 1986-10-15
FR2555899B1 (fr) 1988-10-14
JPS60136514A (ja) 1985-07-20
GB8428710D0 (en) 1984-12-27
GB8332265D0 (en) 1984-01-11
GB2150435A (en) 1985-07-03
FR2555899A1 (fr) 1985-06-07
DE3443858A1 (de) 1985-06-13

Similar Documents

Publication Publication Date Title
JP4491136B2 (ja) 関節症を治療するためのファルネシルタンパク質トランスフェラーゼ阻害剤
CN111635309B (zh) 一种新型解热镇痛药物及其制备方法和用途
JP2022525202A (ja) 肺動脈性肺高血圧症および各種疾患に伴う肺動脈性肺高血圧症の治療法と１日あたりの投薬量
US4694024A (en) Combination product composed of pyrimido-pyrimidines and O-acetylsalicylic acid or its pharmacologically tolerated salts, and its use
JPH11507921A (ja) 新規な医薬用途
KR940011244B1 (ko) 신장 질환 치료제
EA007952B1 (ru) Применение ирбесартана для изготовления лекарств, которые пригодны для предупреждения или лечения лёгочной артериальной гипертензии
US4814353A (en) Therapeutic and prophylactic agent for gastritis
JPH0333126B2 (enrdf_load_stackoverflow)
CA2112195A1 (en) Preventive and therapeutic agent for arteriosclerosis
KR20170106485A (ko) 요산 또는 통풍 질환의 예방 또는 치료
JPH0152363B2 (enrdf_load_stackoverflow)
JPH0352816A (ja) 腎炎の治療剤
MXPA06011823A (es) Terapia de combinacion, que comprende un antagonista del receptor de la adenosina a1 y un inhibidor de la aldosterona.
EP2123277B1 (en) Preventive or therapeutic agent for inflammatory bowel disease
JPH0588684B2 (enrdf_load_stackoverflow)
JPH0119A (ja) 腎機能改善剤
JP2548223B2 (ja) 腎臓疾患治療剤
JP4426654B2 (ja) 免疫調節用医薬組成物
JP2681085B2 (ja) 胃炎治療剤
JPH0138086B2 (enrdf_load_stackoverflow)
JP2009143929A (ja) 睡眠障害の予防・治療剤
JPS627167B2 (enrdf_load_stackoverflow)
US4555510A (en) Therapeutic agent for hypertension
JPH0959158A (ja) ベンズイミダゾール誘導体を含有するぜん息治療剤